Skip to main content
SpringerLink
Log in

Diacerein

A Viewpoint by Maxime Dougados

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Group for the Respect of Ethics and Excellence in Sciences. Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis 1996; 55: 552–7

    Article  Google Scholar 

  • Dougados M, Gueguen A, Nguyen M, et al. Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status. Ann Rheum Dis 1996; 55: 356–62

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de Rhumatologie, Hôpital Cochin, Université René Descartes, Paris, France

    Maxime Dougados

Authors
  1. Maxime Dougados
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dougados, M. Diacerein. Drugs 53, 107 (1997). https://doi.org/10.2165/00003495-199753010-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199753010-00008

Keywords

Search

Navigation